Print this page    •   Back to Web version of article

Retroviruses Conference: Johns Hopkins Report

By John S. James

February 28, 2001

The March 1, 2001 issue of The Hopkins HIV Report has several short, focused summaries of some of the important treatment information from the recent Retroviruses conference (8th Conference on Retroviruses and Opportunistic Infections, Chicago, February 4-8, 2001). Written "for practitioners caring for patients with HIV/AIDS," it can also inform patients who have educated themselves about the disease. Because it targets busy people, the articles are short and to the point. This issue of The Hopkins HIV Report focuses heavily on antiretrovirals, and also includes an important section on hepatitis C.

Other major topics include the new treatment guidelines (see Obtaining the New HIV Treatment Guidelines in this issue), new antiretrovirals in development, when to start antiretroviral therapy, treating experienced patients, drug concentrations and interactions, adherence, and women's issues.

A table of contents with links to each of the articles is at: http://hopkins-aids.edu/publications/report/mar01_toc.html

For those without Web access, here are instructions for ordering by mail: The Hopkins HIV Report is available for free upon request. All requests to be added to their mailing list should include complete mailing information and be sent to: The Hopkins HIV Report, P.O. Box 5252, Baltimore, MD 21224, Attn: Distribution. Change of address should be mailed to the address listed above as well. All other correspondence should be sent to Mary Beth Hansen, Managing Editor, The Hopkins HIV Report, JHU Division of Infectious Diseases, 2700 Lighthouse Point East, Suite 220, Baltimore, MD 21224.

Some Highlights of the Johns Hopkins Retroviruses Conference Issue

The Hopkins HIV Report also includes sections on hepatitis C co-infection (and hepatitis B), and on adherence. These are difficult to summarize. Hepatitis C received much attention at this conference. It is probably the most important co-infection today in persons with HIV [at least in the U.S.]. HIV accelerates progression of hepatitis C, and liver disease due to hepatitis C is becoming an increasingly important cause of illness and death in persons with HIV.


ISSN # 1052-4207

Copyright 2001 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.


Back to the AIDS Treatment News February 28, 2001 contents page.




This article was provided by AIDS Treatment News. It is a part of the publication AIDS Treatment News. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art31993.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.